Caring for Transgender and Gender-Diverse Patients With Migraine: Jennifer Hranilovich, MD

Creating a respectful and welcoming environment is vital for all patients in the clinical care setting, but for transgender and gender-diverse patients—a historically stigmatized population—feeling supported can help bridge gaps in care and improve patient-provider communication. 

According to Jennifer Hranilovich, MD, assistant professor, pediatrics and neurology, Headache Program, University of Colorado School of Medicine/Children's Hospital Colorado, this can be accomplished by simply affirming patients’ gender identity, and directly asking patients for their preferred pronouns and name in conversation. Offices can also opt to use of electronic medical record systems that feature sexual and gender identity prominently, making it easier for clinicians and staff to interact with patients. 

Discussing a recent narrative review conducted to investigate headache in transgender and gender-diverse patients, Hranilovich also commented on the importance of identifying drug-drug interactions in patients who may be receiving gender affirming hormone therapy (GAHT). Areas in need of further research include epidemiology of headache in this population, understanding the difference between people who do and do not receive GAHT, as well as the effects of pubertal suppression.